文献
J-GLOBAL ID:202202253680269055
整理番号:22A0774672
EGFR変異進行非小細胞肺癌患者における次世代シークエンシング液体生検誘導オシメルチニブ再菌血症【JST・京大機械翻訳】
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
著者 (8件):
Fuchs Vered
(Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel)
,
Kian Waleed
(The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel)
,
Lichtenberg Rachel
(Medical School for International Health, Ben-Gurion University of the Negev, Beer Sheva, Israel)
,
Cooper Jonah M.
(Medical School for International Health, Ben-Gurion University of the Negev, Beer Sheva, Israel)
,
Remilah Areen A.
(The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel)
,
Levin Daniel
(The Institute of Nuclear Medicine and Molecular Imaging, Beer-Sheva, Israel)
,
Peled Nir
(The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel)
,
Roisman Laila C.
(The Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel)
資料名:
Clinical Drug Investigation
(Clinical Drug Investigation)
巻:
42
号:
2
ページ:
185-192
発行年:
2022年
JST資料番号:
T0873A
ISSN:
1173-2563
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
ドイツ (DEU)
言語:
英語 (EN)